Rivaroxaban

Rivaroxaban is an oral anticoagulant drug used to prevent blood clot formation. It belongs to a class of medications called factor Xa inhibitors and works by blocking certain proteins, in particular factor Xa, that are involved in the clotting process of the body. This helps reduce the risk of deep vein thrombosis and other serious and life-threatening blood clots. Rivaroxaban is used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). Additionally, it is used to treat or prevent deep vein thrombosis and pulmonary embolism. Rivaroxaban is also used in certain conditions to reduce the risk of major cardiovascular events, such as death and heart attack, in adults with coronary artery disease or peripheral arterial disease.

← Journal of Thrombosis and treatments

Related Articles

1 journal(s) found

Thrombosis and treatments

ISSN: Coming Soon
Type: Open Access Journal
Editor: Max Saito, Federal University of Rio Grande do Sul
Journal of Thrombosis and treatments mainly concentrates on the leading science concerned to the important therapeutic complications of thrombosis, bleeding disorders, and vascular biology through the diffusion and transfer of science, and suggestions within the universal research community.